{"id":112793,"name":"HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION","slug":"hereditary-hemorrhagic-telangiectasia-foundation","state":"MD","country":"United States of America","description":"patient advocacy organization for individuals suffering from a rare disease","totalSpending":330000,"filings":33,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":40000},{"year":2020,"income":50000},{"year":2021,"income":40000},{"year":2022,"income":40000},{"year":2023,"income":40000},{"year":2024,"income":40000},{"year":2025,"income":40000}],"issues":["DEF","HCR","BUD","MED"],"firms":["CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C."],"lobbyists":["MARK VIETH"],"govEntities":["HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE"],"sampleDescriptions":["Research opportunities at the Department of Defense\nHR 3219/ HR 3354, FY 18 Defense Appropriations Act, defense medical research\nHR 1625, Consolidated Appropriations Act FY19, defense medical research","Research opportunities at the Department of Defense and the Centers for Disease Control.\nHR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.\nHR 3219/HR 3354,","Research opportunities at the Department of Defense and the Centers for Disease Control.\nHR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.\nHR 3219/HR 3354,","Research opportunities at the Department of Defense and the Centers for Disease Control.\nHR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.\nHR 3219/HR 3354,","Research opportunities at the Department of Defense\nHR 6157/S 3159, FY19 Defense Appropriations Act, defense medical research"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}